Compounds > celiprolol

celiprolol and transforming growth factor beta

celiprolol has been researched along with transforming growth factor beta in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, N; Matsuoka, H; Mita, S; Tsubokou, Y; Yoshida, K1
Brooke, BS1

Other Studies

2 other study(ies) available for celiprolol and transforming growth factor beta

ArticleYear
Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats.
    European journal of pharmacology, 2002, Dec-20, Volume: 457, Issue:2-3

    Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Body Weight; Celiprolol; Desoxycorticosterone; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hypertension; Male; Mitogen-Activated Protein Kinases; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling

2002
Celiprolol therapy for vascular Ehlers-Danlos syndrome.
    Lancet (London, England), 2010, Oct-30, Volume: 376, Issue:9751

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aneurysm, Ruptured; Aortic Dissection; Celiprolol; Ehlers-Danlos Syndrome; Humans; Signal Transduction; Transforming Growth Factor beta; Vascular Diseases

2010